Matches in Wikidata for { <http://www.wikidata.org/entity/Q96605089> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q96605089 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q96605089 description "scientific article published on 30 May 2020" @default.
- Q96605089 description "wetenschappelijk artikel" @default.
- Q96605089 description "наукова стаття, опублікована 30 травня 2020" @default.
- Q96605089 name "hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation In Vitro" @default.
- Q96605089 name "hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation In Vitro" @default.
- Q96605089 type Item @default.
- Q96605089 label "hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation In Vitro" @default.
- Q96605089 label "hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation In Vitro" @default.
- Q96605089 prefLabel "hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation In Vitro" @default.
- Q96605089 prefLabel "hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation In Vitro" @default.
- Q96605089 P1433 Q96605089-72F03EB8-B178-4E8D-8FB2-B10B85A9CB0B @default.
- Q96605089 P1476 Q96605089-2569BB9C-3DDF-40A2-92D0-1B71099AA793 @default.
- Q96605089 P2093 Q96605089-3C29BCF9-5401-4AF0-A8BF-C5F8056ACD0F @default.
- Q96605089 P2093 Q96605089-99003EAA-AC2C-4116-8006-2AF73FD72CBE @default.
- Q96605089 P2093 Q96605089-A233390A-79C1-4122-ADBE-9F775488606E @default.
- Q96605089 P2093 Q96605089-AD90E5CD-5B20-4154-B484-8C2B3DB5CDF3 @default.
- Q96605089 P2093 Q96605089-E4A01ADE-ED8F-486F-A5BD-A85026005AFB @default.
- Q96605089 P2093 Q96605089-F88B5115-A3F7-4A51-BFFB-D138264494D4 @default.
- Q96605089 P275 Q96605089-1E038BE9-BFEA-4BFA-9886-DCD800898433 @default.
- Q96605089 P304 Q96605089-AAED0334-0D0B-4A08-BFE6-1E794C3D12F4 @default.
- Q96605089 P31 Q96605089-77B7B867-91A7-4F19-A140-B4CB13A46037 @default.
- Q96605089 P356 Q96605089-DF355873-F72F-4250-934C-87B9AD853509 @default.
- Q96605089 P478 Q96605089-588642EE-A973-4CD0-8A73-C45F3A22665E @default.
- Q96605089 P50 Q96605089-3FC05FB2-CA9B-447F-8CEA-96ACAE605F23 @default.
- Q96605089 P577 Q96605089-71E2A328-248C-496F-9400-DBBE6D330BB8 @default.
- Q96605089 P6216 Q96605089-812E2B84-A651-4285-BFAB-E85D6E37E8E3 @default.
- Q96605089 P698 Q96605089-50FE7087-0CE9-4779-BE27-2AE449E13F16 @default.
- Q96605089 P921 Q96605089-E30A3E68-A450-4D91-84ED-0823236488F0 @default.
- Q96605089 P356 6458791 @default.
- Q96605089 P698 32565727 @default.
- Q96605089 P1433 Q2144494 @default.
- Q96605089 P1476 "hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-κB Pathway and VE-Cadherin/β-Catenin Signaling Modulation In Vitro" @default.
- Q96605089 P2093 "Dan Tang" @default.
- Q96605089 P2093 "Hexin Yan" @default.
- Q96605089 P2093 "Linjie Zhu" @default.
- Q96605089 P2093 "Tianjie Yuan" @default.
- Q96605089 P2093 "Yi Chen" @default.
- Q96605089 P2093 "Yingfu Jiao" @default.
- Q96605089 P275 Q20007257 @default.
- Q96605089 P304 "6458791" @default.
- Q96605089 P31 Q13442814 @default.
- Q96605089 P356 "10.1155/2020/6458791" @default.
- Q96605089 P478 "2020" @default.
- Q96605089 P50 Q91215401 @default.
- Q96605089 P577 "2020-05-30T00:00:00Z" @default.
- Q96605089 P6216 Q50423863 @default.
- Q96605089 P698 "32565727" @default.
- Q96605089 P921 Q411114 @default.